Effect of a multifaceted quality improvement intervention on hospital personnel adherence to performance measures in patients with acute ischemic stroke in China: A randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 320, Issue 3, 2018, Pages 245-254

  Wang, Yongjun ^a,b   Wang, Yilong ^a,b   Li, Zixiao ^a,b   Zhao, Xingquan ^a,b   Wang, Chunjuan ^a,b   Wang, Xianwei ^a   Wang, David ^c   Liang, Li ^e   Liu, Liping ^a   Wang, Chunxue ^a   Li, Hao ^a   Shen, Haipeng ^d   Bettger, Janet ^e   Pan, Yuesong ^a   Jiang, Yong ^a   Yang, Xiaomeng ^a   Zhang, Changqing ^a   Han, Xiujie ^f   Meng, Xia ^a   Yang, Xin ^a   Kang, Hong ^g   Yuan, Weiqiang ^h   Fonarow, Gregg C ⁱ   Peterson, Eric D ^e   Schwamm, Lee H ^j   Xian, Ying ^e   more..

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

^c UNIVERSITY OF ILLINOIS   (United States)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^f Anshanshi Changda Hospital   (China)

^g General Hospital of Benxi Iron and Steel   (China)

^h The Second People's Hospital of Hengshui   (China)

ⁱ UCLA MEDICAL CENTER   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALL CAUSE MORTALITY; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHINA; CLINICAL PROTOCOL; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE REGISTRY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; HEALTH PERSONNEL ATTITUDE; HOSPITAL MORTALITY; HOSPITAL PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PATIENT MONITORING; PERFORMANCE MEASUREMENT SYSTEM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RANKIN SCALE; TOTAL QUALITY MANAGEMENT; CLINICAL TRIAL; COMPARATIVE STUDY; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; MIDDLE AGED; MORTALITY; PROTOCOL COMPLIANCE; PUBLIC HOSPITAL; SECONDARY PREVENTION; STANDARDS; TREATMENT OUTCOME;

AGED; BRAIN ISCHEMIA; CHINA; EVIDENCE-BASED MEDICINE; FEMALE; GUIDELINE ADHERENCE; HOSPITAL MORTALITY; HOSPITALS, PUBLIC; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERSONNEL, HOSPITAL; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; SECONDARY PREVENTION; STROKE;

EID: 85050406827     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.8802     Document Type: Article

References (31)

1. Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245-254. doi:10.1016/S0140-6736(13)61953-4
2. Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10015):251-272. doi:10.1016/S0140-6736 (15)00551-6
3. Wang W, Jiang B, Sun H, et al; NESS-China Investigators. Prevalence, incidence, and mortality of stroke in China: results from a nationwide population-based survey of 480 687 adults. Circulation. 2017;135(8):759-771. doi:10.1161/CIRCULATIONAHA.116.025250
4. Kernan WN, Ovbiagele B, Black HR, et al. Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014;45(7):2160-2236. doi:10.1161/STR.0000000000000024
5. Jauch EC, Saver JL, Adams HP Jr, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke. 2013;44(3): 870-947. doi:10.1161/STR.0b013e318284056a
6. Li Z, Wang C, Zhao X, et al; China National Stroke Registries. Substantial progress yet significant opportunity for improvement in stroke care in China. Stroke. 2016;47(11):2843-2849. doi:10.1161/STROKEAHA.116.014143
7. Cabana MD, Rand CS, Powe NR, et al. Why don't physicians followclinical practice guidelines? a framework for improvement. JAMA. 1999;282(15): 1458-1465. doi:10.1001/jama.282.15.1458
8. Chauhan BF, Jeyaraman MM, Mann AS, et al. Behavior change interventions and policies influencing primary healthcare professionals' practice-an overview of reviews [published correction appears in Implement Sci. 2017;12 (1):38]. Implement Sci. 2017;12(1):3. doi:10.1186/s13012-016-0538-8
9. Berwanger O, Guimarães HP, Laranjeira LN, et al; Bridge-Acs Investigators. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial. JAMA. 2012;307(19): 2041-2049. doi:10.1001/jama.2012.413
10. Schwamm LH, Fonarow GC, Reeves MJ, et al. Get With the Guidelines-Stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation. 2009;119(1):107-115. doi:10.1161/CIRCULATIONAHA.108.783688
11. Ormseth CH, Sheth KN, Saver JL, Fonarow GC, Schwamm LH. The American Heart Association's Get With the Guidelines (GWTG)-Stroke development and impact on stroke care. Stroke Vasc Neurol. 2017;2(2): 94-105. doi:10.1136/svn-2017-000092
12. Middleton S, McElduff P, Ward J, et al; QASC Trialists Group. Implementation of evidence-based treatment protocols to manage fever, hyperglycaemia, and swallowing dysfunction in acute stroke (QASC): a cluster randomised controlled trial. Lancet. 2011;378(9804):1699-1706. doi:10.1016/S0140-6736(11)61485-2
13. Scott PA, Meurer WJ, Frederiksen SM, et al; INSTINCT Investigators.Amultilevel intervention to increase community hospital use of alteplase for acute stroke (INSTINCT): a cluster-randomised controlled trial. Lancet Neurol. 2013;12(2):139-148. doi:10.1016/S1474-4422(12)70311-3
14. Lakshminarayan K, Borbas C, McLaughlin B, et al. Acluster-randomized trial to improve stroke care in hospitals. Neurology. 2010;74(20):1634-1642. doi:10.1212/WNL.0b013e3181df096b
15. Johnston SC, Sidney S, Hills NK, et al. Standardized discharge orders after stroke: results of the quality improvement in stroke prevention (QUISP) cluster randomized trial. Ann Neurol. 2010; 67(5):579-589.
16. Wang Y, Li Z, Xian Y, et al. Rationale and design of a cluster-randomized multifaceted intervention trial to improve stroke care quality in China: theGOLDEN BRIDGE-Acute Ischemic Stroke.AmHeart J. 2015;169 (6):767-774.
17. Minister of Health. Acts for Hospital Classification. China: Minister of Health, 1989.
18. Ministry of Health. Brief introduction: 2013 China statistical yearbook [in Chinese]. http://www.nhfpc.gov.cn/htmlfiles/zwgkzt/ptjnj/year2013/index2013.html. Accessed April 5, 2018.
19. The writing group of the early management of patients with acute ischemic stroke of cerebrovascular disease group of neurologic branch of Chinese Medical Association. Chinese guidelines for the early management of patients with acute ischemic stroke 2010[in Chinese]. Chin J Neurol. 2010;43(2):146-153. doi:10.3760/cma.j.issn.1006-7876.2010.02.022
20. National Institute of Neurological Disorders and Stroke rt-PAStroke Study Group. Tissue plasminogen activator for acute ischemic stroke.NEngl J Med. 1995;333(24):1581-1587. doi:10.1056/NEJM199512143332401
21. Jo B, Asparouhov T, Muthén BO. Intention-totreat analysis in cluster randomized trials with noncompliance. Stat Med. 2008;27(27):5565-5577. doi:10.1002/sim.3370
22. Barber SL, Borowitz M, Bekedam H, Ma J. The hospital of the future in China: China's reform of public hospitals and trends from industrialized countries. Health Policy Plan. 2014;29(3):367-378. doi:10.1093/heapol/czt023
23. PetersonED, Delong ER, Masoudi FA, et al; ACCF/AHATask Force on Performance Measures. ACCF/AHA2010 position statement on composite measures for healthcare performance assessment. Circulation. 2010;121(15):1780-1791. doi:10.1161/CIR.0b013e3181d2ab98
24. Fonarow GC, Reeves MJ, Smith EE, et al; GWTG-Stroke Steering Committee and Investigators. Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes. 2010;3(3):291-302. doi:10.1161/CIRCOUTCOMES.109.921858
25. FonarowGC, Zhao X, Smith EE, et al. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative. JAMA. 2014;311(16):1632-1640. doi:10.1001/jama.2014.3203
26. Puffer S, TorgersonDJ, Watson J. Cluster randomized controlled trials. J Eval Clin Pract. 2005;11 (5):479-483. doi:10.1111/j.1365-2753.2005.00568.x
27. Panella M, Marchisio S, Brambilla R, Vanhaecht K, Di Stanislao F.Acluster randomized trial to assess the effect of clinical pathways for patients with stroke: results of the clinical pathways for effective and appropriate care study.BMCMed. 2012;10:71. doi:10.1186/1741-7015-10-71
28. McCarney R, Warner J, Iliffe S, van Haselen R, Griffin M, Fisher P. TheHawthorne Effect: a randomised, controlled trial.BMCMedResMethodol. 2007;7:30. doi:10.1186/1471-2288-7-30
29. Puffer S, Torgerson D, Watson J. Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ. 2003;327(7418):785-789. doi:10.1136/bmj.327.7418.785
30. Hsieh FI, Lien LM, Chen ST, et al; Taiwan Stroke Registry Investigators. Get With the Guidelines-Stroke performance indicators: surveillance of stroke care in the Taiwan Stroke Registry: Get With the Guidelines-Stroke in Taiwan. Circulation. 2010;122(11):1116-1123. doi:10.1161/CIRCULATIONAHA.110.936526
31. Salinas J, Schwamm LH. Behavioral interventions for stroke prevention: the need for a new conceptual model. Stroke. 2017;48(6):1706-1714. doi:10.1161/STROKEAHA.117.015909